VICTORIA, Oct. 16 /PRNewswire-FirstCall/ - Aspreva Pharmaceuticals Corporation (NASDAQ: ASPV; TSX: ASV) today announced preliminary and unaudited net revenues of approximately US $62 million for the third quarter of 2007 compared to US $47.9 million revenue in the third quarter of 2006.
As previously announced, Aspreva will release its full financial results on Wednesday, October 31, 2007. The Company will hold a conference call and webcast beginning at 2:00 p.m. Pacific Time (5 p.m. Eastern Time) to discuss results and to provide a general corporate update.
About Aspreva Pharmaceuticals
Aspreva is a global pharmaceutical company focused on identifying, developing, and, upon approval, commercializing evidence-based medicines for patients living with less common diseases. Aspreva common stock is traded on the NASDAQ Global Select Market under the trading symbol "ASPV" and on the Toronto Stock Exchange under the trading symbol "ASV". Learn more at http://www.aspreva.com.
Aspreva will host a conference call to discuss results for the third quarter 2007 on Wednesday, October 31, 2007 at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time).
North America (toll free): 1-866-202-0886
Enter passcode: 14829169
The call will be available for replay until Wednesday, November 7th, by calling 1-888-286-8010 (North America) or 1-617-801-6888 (International) and entering the pass code 79726236.
A live webcast will also be available to all interested parties on
Aspreva's website: http://www.aspreva.com. Plea
|SOURCE Aspreva Pharmaceuticals|
Copyright©2007 PR Newswire.
All rights reserved